NIMENRIX should be used in accordance with available official recommendations.
Recommended Dose and Dosage Adjustment
|Age Group||Primary Immunization||Booster|
|Infants from 6 weeks to less than 6 months of age*|
Two doses, each of 0.5 mL, with the first dose given from 6 weeks of age, and with an interval of 2 months between doses
|At 12 months of age|
|Unvaccinated infants from 6 months to less than 12 months of age**||One dose of 0.5 mL given from 6 months of age||At 12 months of age with a minimum interval of at least 2 months after the primary dose|
|Children from 12 months of age, adolescents and adults**||One dose of 0.5 mL||Not routinely administered|
NIMENRIX may be given as a booster dose to individuals who have previously received primary vaccination with NIMENRIX or other conjugated or plain polysaccharide meningococcal vaccines (see WARNINGS AND PRECAUTIONS – Protection Against Meningococcal Disease: Persistence of serum bactericidal antibody titres and CLINICAL TRIALS.
NIMENRIX is for intramuscular injection only.
The injection sites are the anterolateral aspect of the thigh in infants, or the anterolateral aspect of the thigh or deltoid muscle in individuals from 12 months of age (see WARNINGS AND PRECAUTIONS and DRUG INTERACTIONS).
For instructions on reconstitution of the vaccine before administration, see SPECIAL HANDLING INSTRUCTIONS.
The reconstituted vaccine is a clear colourless solution.
The reconstituted vaccine should be inspected visually for any foreign particulate matter and/or variation of physical aspect prior to administration. In the event of either being observed, discard the vaccine.
Any unused product or waste material should be disposed of in accordance with local requirements.